Figure 5
Figure 5. TxA2 released from WT platelets restores aggregation of CalDAG-GEFI−/− platelets. (A) Aggregation traces of platelets (108 cells) activated with 10 μg/mL collagen. The aggregation response of WT (black line), CalDAG-GEFI−/− (knockout [KO], light gray line), or CalDAG-GEFI−/− platelets containing 10% WT platelets (dark gray line) was studied. WT platelets were pretreated with 1 mM aspirin (acetylsalicylic acid) before addition to CalDAG-GEFI−/− platelets to inhibit TxA2 release. CalDAG-GEFI−/− platelets were pretreated with 40 μg/mL blocking antibody to αIIbβ3 to demonstrate that the aggregation was integrin-dependent. Traces are representative of 3 individual experiments. (B) Representative images showing aggregates of calcein green–labeled WT and/or calcein red–labeled KO (CalDAG-GEF−/−) platelets fixed with 3.7% formaldehyde 10 minutes after stimulation and visualized with fluorescence microscopy. Scale bar = 25 μm.

TxA2 released from WT platelets restores aggregation of CalDAG-GEFI−/− platelets. (A) Aggregation traces of platelets (108 cells) activated with 10 μg/mL collagen. The aggregation response of WT (black line), CalDAG-GEFI−/− (knockout [KO], light gray line), or CalDAG-GEFI−/− platelets containing 10% WT platelets (dark gray line) was studied. WT platelets were pretreated with 1 mM aspirin (acetylsalicylic acid) before addition to CalDAG-GEFI−/− platelets to inhibit TxA2 release. CalDAG-GEFI−/− platelets were pretreated with 40 μg/mL blocking antibody to αIIbβ3 to demonstrate that the aggregation was integrin-dependent. Traces are representative of 3 individual experiments. (B) Representative images showing aggregates of calcein green–labeled WT and/or calcein red–labeled KO (CalDAG-GEF−/−) platelets fixed with 3.7% formaldehyde 10 minutes after stimulation and visualized with fluorescence microscopy. Scale bar = 25 μm.

Close Modal

or Create an Account

Close Modal
Close Modal